Pharmaceutical Industry: 2024 Results and 2025 Trends
On January 20, 2025, REVERA, together with its partners – Intellix-M, PharmAssistance, and 103.by – held a webinar where industry experts summarized the results of 2024 and forecasted trends for 2025.
- Intellix-M presented digitized and accumulated data on the retail pharmaceutical market volume for the first 11 months of 2024.
- REVERA's lawyers covered the outcomes of 2024 regarding changes in general and special legislation that affected all pharmaceutical market participants. They also highlighted plans for new regulatory document projects in 2025 and identified legal trends.
- A REVERA lawyer discussed the significant changes in the regulation of pharmaceutical advertising, focusing on the key legal aspects in this area.
- PharmAssistance shared insights on the legal and practical aspects of pharmaceutical registration in 2024 and identified upcoming trends for 2025.
- In the promotion of pharmaceutical products, the face of the consumer, tools, and methods are changing. 103.by's experts discussed the key trends of 2024 and the relevant practices for 2025.
The webinar was useful for managers, lawyers, marketers, product managers from pharmaceutical companies, their representatives, distributors, and pharmacies.
